Investors

bi³ offers the opportunity for entrepreneurial scientists to rapidly convert novel biological insights into life-saving and life-changing therapeutics. Our unique model blends the best of a startup’s energy, a venture firm’s capital, and a fully-integrated biotech’s resources to maximize the chances of scientific, clinical and financial success.

 

Research Ventures & Licensing (RVL) is a division of Partners HealthCare that coordinates all commercialization services across Partners HealthCare, Massachusetts General Hospital and Brigham and Women’s Hospital. The intent is for RVL to be a cohesive, coordinated group to service inventors, thought-leaders, entrepreneurs and industry. The team has backgrounds in technology licensing, patenting, bench research, finance, funding, business, law and start-ups.